Tuesday, December 12, 2006

Blue Heron Biotechnology Gets Investment From Invitrogen

Bothell, Washington-based Blue Heron Biotechnology has received an investment from California-based Invitrogen. The investment comes as part of a strategic development and distribution relationship with Invitrogen, a provider of products and services for the life sciences industry. Financial terms of the investment were not disclosed. Invitrogen will gain worldwide rights to distribute Blue Heron's custom gene sysnthesis services. Blue Heron's technology is used to synthesize gene sequences, and is used in the synthetic biology market. The firms also said they will also co-develop new products and services. More information »